Premium
Inhibition of oxidative radical production prevents diabetes‐induced vascular dysfunction through decreased arginase activation
Author(s) -
Yao Lin,
Chandra Surabhi,
Toque Haroldo A,
Xu Zhimin,
Caldwell Ruth B.,
Caldwell R. William
Publication year - 2011
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.25.1_supplement.630.4
Elevated arginase (ARG) activity and expression are associated with various cardiovascular diseases. Our lab previously reported that the oxidative species ONOO − and H 2 O 2 increase arginase activity/expression in bovine aortic endothelial cells (BAEC). Further, a NADPH oxidase (NOX) inhibitor, apocynin attenuated the effect of H 2 O 2 on arginase activity. We hypothesized that inhibiting the production of oxidative radicals in diabetes would prevent vascular endothelial dysfunction by reducing ARG activity/expression. To test this concept, we used bovine aortic endothelial cells (BAEC) treated with high glucose or normal glucose media and aortic tissue from normoglycemic and diabetic wild type (WT) and NOX 2 knockout (KO) mice. ARG activity was increased in high‐glucose treated BAEC (51%) as well as in aorta from WT‐D mice (82%). Both were prevented by 18 hr incubation with ONOO − decomposition catalyst FeTPPS or apocynin. Aorta from WT diabetic mice exhibited marked reduction of maximum endothelium‐dependent relaxation to acetylcholine (48%) compared to WT mice (62%). Vasorelaxation in the NOX 2 KO diabetic mice was comparable with that in NOX 2 KO normoglycemic mice. In conclusion, reduction in the levels of NOX‐derived oxidative radicals prevents diabetes‐induced elevation of arginase activity and preserves endothelium dependent vasorelaxation. (Support NIH HL70215, NIH EY11766)